Funding This investigator-initiated prospective cohort study was supported by an unrestricted grant from AOP Orphan Pharmaceuticals GmbH, a member of the AOP Health Group, Vienna, Austria
Expert Opin Pharmacother (2006) 7:2095105
This work has been done within the efforts of the European Reference Network EpiCARE ( Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
The University of Wisconsin Translational Research Initiatives in Pathology laboratory (TRIP), supported by the UW Department of Pathology and Laboratory Medicine, UWCCC (P30 CA014520) and the Office of The Director- NIH (S10 OD023526)
DevaneWAHanuLBreuerAPertweeRGStevensonLAGriffinGet al
Ratan RR, Murphy TH, Baraban JM